Individual compounds from flavonoids and carotenoids have been tested for mechanisms in important drug targets, MAO (MAOA and MAOB) and BDNF [15,50,60,61,62,63], which are known to be associated with depression through molecular docking studies for possible inhibitory roles. This evidence concerns the gene MAOB and depressive symptom measurement.